Microbiological tests on oral pediatric medicines - Requirements for an improved pharmacopoeia monograph

Annals of Pharmacotherapy

Volumn 40, Issue 1, 2006, Pages 158-159

  Long, Paul F ^a   Han, Jihong ^a   Tuleu, Catherine ^a   Wong, Ian Chi Kei ^a,b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; GLYCEROL; PRESERVATIVE; RNA 16S; RNA 18S;

BIODEGRADATION; COST CONTROL; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG FORMULARY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STORAGE; LETTER; MICROBIOLOGICAL EXAMINATION; MICROORGANISM DETECTION; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHELF LIFE; SYRUP;

ADMINISTRATION, ORAL; CHILD; DRUG CONTAMINATION; HUMANS; MICROBIOLOGICAL TECHNIQUES; PHARMACEUTICAL PREPARATIONS; PHARMACOPOEIAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; RNA, RIBOSOMAL, 18S;

EID: 32344438094     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G349     Document Type: Letter

References (9)

1. Nunn AJ. Making medicines that children can take. Arch Dis Child 2003;88:369-71.
2. De la Rosa MC, Mosso MA, Garcia ML, Plaza C. Resistance to the antimicrobial agents of bacteria isolated from non-sterile pharmaceuticals. J Appl Bacteriol 1993;74:570-7.
3. British pharmacopoeia. London: UK Department of Health, 2004:A331-51.
4. United States pharmacopoeia. 27th rev. Washington, DC: USP Convention, 2004:2157-62.
5. European pharmacopoeia. IVth ed. Directorate for the Quality of Medicines of the Council of Europe, 2.6.1, 2.6.12, 2.6.13, 123-6, 136-40.
6. Manu-Tawiah W, Brescia BA, Montgomery ER. Setting threshold limits for the significance of objectionable micro-organisms in oral pharmaceutical products. PDA J Pharm Sci Technol 2001;55:171-5.
7. Millar BC, Moore JE. Molecular diagnostics: current options. Methods Mol Biol 2004;266:139-66.
8. Medicines for children. London: European Commission, Enterprise and Industry Directorate General, Consumer Goods, Pharmaceutical Sector. http://pharmacos.eudra.org/F2/Paediatrics/index.htm (accessed 2005 Dec 15).
9. Charnock C. The microbial content of non-sterile pharmaceuticals distributed in Norway. J Hosp Infect 2004;57:233-40.